HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COTELLIC safely and effectively. See full prescribing information for COTELLIC. COTELLIC (cobimetinib) tablets, for

First Page		Document Content
Date: 2015-11-10 11:42:30 Chemistry Clinical medicine Organic chemistry MEK inhibitor Protein kinase inhibitors B-Raf inhibitor Sulfonamides Vemurafenib Cobimetinib Keratoacanthoma Ofloxacin		HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COTELLIC safely and effectively. See full prescribing information for COTELLIC. COTELLIC (cobimetinib) tablets, for Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 719,43 KB Share Document on Facebook

	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COTELLIC safely and effectively. See full prescribing information for COTELLIC. COTELLIC (cobimetinib) tablets, for DocID: 1pQS7 - View Document
	CLINICAL Ulcerated upper lip tumour: diagnostic procedure Alejandro Molina-Leyva Vicente Crespo-Lora DocID: 15fIc - View Document
	clinical practice Manuel Gil-Mosquera MD, is a family physician resident, Ramon y Cajal University Hospital, Madrid, Spain. DocID: 12mPw - View Document
	Help us to improve SIGN guidelines click here to complete our survey SIGN 140 • Management of primary cutaneous squamous cell carcinoma A national clinical guideline June 2014 DocID: YoGS - View Document
	CLINICAL Ranjan Gupta Cutaneous manifestation of visceral malignancy: DocID: XNO5 - View Document